News
SEER
1.700
0.00%
0.000
Seer Strengthens Proteograph IP Following Favorable Patent Ruling
TipRanks · 4d ago
PTAB upholds Seer patent for nano- and microparticles in challenge by Bruker
TipRanks · 4d ago
PTAB upholds Seer nanoparticle protein enrichment patent in Bruker challenge
Reuters · 4d ago
Weekly Report: what happened at SEER last week (0323-0327)?
Weekly Report · 4d ago
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries
Barchart · 4d ago
Weekly Report: what happened at SEER last week (0316-0320)?
Weekly Report · 03/23 09:15
Seer Amends Tax Benefit Plan After Stockholder Challenge
TipRanks · 03/16 13:10
Seer Inc. agrees to pay USD 250,000 mootness fee in Delaware Chancery suit
Reuters · 03/16 12:42
Weekly Report: what happened at SEER last week (0309-0313)?
Weekly Report · 03/16 09:15
Weekly Report: what happened at SEER last week (0302-0306)?
Weekly Report · 03/09 09:15
Seer shareholder group sends letter to Seer independent directors
TipRanks · 03/04 13:19
*Radoff-JEC Group Calls on Seer Bd to Immediately Announce Sale Process to Avoid Further Value Destruction Under Farokhzad
Dow Jones · 03/04 13:05
*Radoff-JEC Group Collectively Own About 7.6% of Outstanding Common Stk of Seer
Dow Jones · 03/04 13:05
Radoff-JEC Group urges Seer board to launch sale process ahead of shareholder meeting
Reuters · 03/04 13:00
RADOFF-JEC GROUP: COLLECTIVELY OWN ABOUT 7.6% OF OUTSTANDING COMMON STOCK OF SEER
Reuters · 03/04 13:00
Weekly Report: what happened at SEER last week (0223-0227)?
Weekly Report · 03/02 09:15
Seer Inc. Balances Growth Momentum With Cautious Outlook
TipRanks · 03/02 00:17
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 02/27 12:05
Seer outlines $16M–$18M 2026 revenue target as product innovation accelerates and new buyback approved
Seeking Alpha · 02/27 03:18
Seer (SEER) Q4 2025 Earnings Call Transcript
The Motley Fool · 02/27 01:52
More
Webull provides a variety of real-time SEER stock news. You can receive the latest news about Seer, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About SEER
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.